학술논문
61MO Biomarker analysis of men with enzalutamide (enza)-resistant metastatic castration-resistant prostate cancer (mCRPC) treated with pembrolizumab (pembro) + enza in KEYNOTE-199
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S383-S383
Subject
Language
ISSN
0923-7534